Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

NCT00714285 ·Status: COMPLETED ·Phase: PHASE1

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

NCT03392207 ·Status: COMPLETED

Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

NCT05779020 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

NCT01323946 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogencity of H7N9 Influenza Antigen With 2 Adjuvant Formulations in Healthy Adults in Brazil

NCT03330899 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

NCT01144299 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults

NCT02915809 ·Status: UNKNOWN ·Phase: PHASE3

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

NCT00989287 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines

NCT01111968 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

NCT02894840 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above

NCT02369341 ·Status: COMPLETED ·Phase: PHASE3

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

NCT00125944 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children

NCT01196988 ·Status: COMPLETED ·Phase: PHASE3

Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute

NCT03057483 ·Status: COMPLETED

Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese Volunteers

NCT01123954 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

NCT05027932 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination

NCT00889889 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

NCT03859141 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

NCT03853993 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

NCT00968539 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects

NCT01357265 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults

NCT02148328 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children

NCT01198756 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011

NCT01152814 ·Status: COMPLETED ·Phase: PHASE2